Respiratory Care Devices Market

Market Study on Respiratory Care Devices: North America to Remain Leading Regional Market

Respiratory Care Devices Market Segmented By Diagnostic Devices, Therapeutic Devices, Monitoring Devices Product in Hospitals, Home Care

  • September-2022
  • PMRREP3683
  • 250 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Respiratory Care Devices Market Outlook (2022-2032)

The global respiratory care devices market is anticipated to increase from a valuation of US$ 18.5 Bn in 2022 to US$ 41 Bn by the end of 2032, expanding at a high-value CAGR of 8.3%.

Based on product, therapeutic devices account for the largest market share, while regional analysis reveals that North America accounts for over half of the global market share.

Respiratory Care Devices Market Size (2022E)

US$ 18.5 Bn

Projected Sales of Respiratory Care Devices (2032F)

US$ 41 Bn

Global Market Growth Rate (2022-2032)

8.3% CAGR

Value Share of North America (2021A)

51.5%

Find Out More about the Report Coverage

Companies

  • Philips Healthcare
  • Masimo Corporation
  • Fisher and Paykel Healthcare Limited
  • ResMed, Inc.
  • Covidien plc.
  • CareFusion Corporation

Which Factors Serve as Revenue Generators for Respiratory Care Device Manufacturers?

“Rising Count of Chronic Pulmonary Obstructive Diseases”

In recent years, there has been a noticeable increase in the number of patients suffering from chronic pulmonary obstructive diseases. The growing incidence of these diseases is attributed to the constant changes in lifestyles along with environmental factors such as increasing pollution levels.

In addition, the launching of novel products and a strong pipeline of respiratory care devices are also predicted to propel the sales opportunities in the market.

  • Philips launched the PHILIPS RESPIRONICS E30 VENTILATOR in April 2020. This innovation will be helpful for healthcare professionals while providing them with superior quality ventilators.

“Increasing Geriatric Population across the World”

In the past few years, there has been a significant increase in the population of geriatric people around the world.

  • As per data provided by WHO (World Health Organization), more than 2 billion people are likely to be of age 60 and older by the end of 2050.

These people are prone to different respiratory diseases owing to their weaker immune systems. This rising count of respiratory diseases, resulting in the increased need for effective healthcare solutions for elderly people, will stimulate sales opportunities in the market.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

How is Market Expansion Being Limited to Some Extent?

“Lack of Awareness in Developing Regions about Advanced Products”

Several developing regions across the globe are unaware or less aware of the services from the respiratory care devices market. This factor is predicted to limit the adoption of these solutions in the industry.

Some harmful effects of respiratory care devices on numerous neonates are estimated to limit growth avenues in the market. In addition, excise tax on respiratory care devices by some countries is also projected to have an adverse impact on product sales over the coming years.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

North America to Dominate in Respiratory Care Devices Market

North America has been projected to hold the largest share in the respiratory care devices industry, followed by Europe.

Growth avenues in the market are attributed to the highly developed healthcare infrastructure in these regions. Along with this, a large patient pool suffering from respiratory diseases owing to lifestyle changes, including tobacco habits and smoking, is expected to contribute to the growth opportunities in these regional markets.

Further, the easy availability of various trained personnel for the operation of advanced respiratory devices has also been predicted to aid market expansion.

respiratory-care-devices-market

Explore Persistence Market Research’s expertise in promulgation of the business !

Respiratory Care Devices

Respiratory care devices are the branch of medical devices focused on the treatment, management, control, diagnostic evaluation, and care of patients with abnormalities in the cardiopulmonary system.

The devices are used in chronic obstructive pulmonary diseases (COPD), a degenerative lung diseases, which primarily include chronic bronchitis and emphysema. The market is witnessing decent growth as COPD is one of the leading causes of death globally.

Market Segmentation

In the product segment, the respiratory therapeutic devices market accounted for the largest share globally in 2014. Major driving factors for the therapeutic devices market were increasing adoption of various devices such as humidifiers, nebulizers, and oxygen concentrators due to the increasing prevalence of respiratory diseases, and the rising geriatric population.

Key Players

Key players in the global respiratory care devices market are Philips Healthcare (Netherlands), Masimo Corporation (U.S.), Fisher and Paykel Healthcare Limited (New Zealand), ResMed, Inc. (U.S.), Covidien plc (Ireland), and CareFusion Corporation (U.S.).

Respiratory Care Devices Industry Report Scope

Attribute

Details

Forecast period

2022-2032

Historical data available for

2017-2021

Market analysis

USD million for value

Key regions covered

  • North America
  • Europe
  • Latin America
  • East Asia
  • The Middle East & Africa
  • South Asia & Pacific

Key countries covered

  • U.S.
  • Canada
  • UK
  • Germany
  • France
  • Spain
  • Turkey
  • Italy
  • Japan
  • China
  • India
  • South Korea
  • Brazil
  • Mexico
  • South Africa
  • GCC
  • UAE

Key market segments covered

  • Product
  • End User
  • Region

Key companies profiled

  • Philips Healthcare
  • Masimo Corporation
  • Fisher and Paykel Healthcare Limited
  • ResMed, Inc.
  • Covidien plc.
  • CareFusion Corporation

Report Coverage

  • Market Forecast
  • Company Share Analysis
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & pricing

Available upon request

Respiratory Care Devices Industry Research by Category

By Product Type:

  • Diagnostic Devices
  • Therapeutic Devices
  • Monitoring Devices

By End User:

  • Hospitals
  • Home Care

By Region:

  • North America
  • Europe
  • Latin America
  • East Asia
  • Middle East & Africa
  • South Asia & Pacific

- FAQs -

The current value of the respiratory care devices market is 18.5 Bn.

Based on product type, therapeutic devices lead the market.

North America accounted for a leading market share of 51.5% at the end of 2021.

Philips Healthcare, Masimo Corporation, Fisher and Paykel Healthcare Limited, ResMed, Inc., Covidien Plc., and CareFusion Corporation are prominent respiratory care device manufacturers.

Recommendations

Noninvasive Ventilation Masks And Circuits Market

Global Market Study on Non-invasive Ventilation Masks and Circuits: Wide-Ranging Application in Array of Scientific Disciplines Complementing Market Growth .

Airway Clearance System Market

Airway clearances are thus turning out to be the ultimate choice as they convert liquid medication into aerosol or mist. Moreover, the rise in per capita income is influencing individuals to spend more on health care, as healthcare concerns are increasing with increasing living standards..

Smart Inhalers Market

Global smart inhalers market to rake in revenue worth more than US$ 1 Bn by the end of 2031, which was just around US$ 120 Mn in 2020.

Nebulizer Devices Market

Global Nebulizer Devices Market is projected to rise to a valuation of over US$ 3,382 Mn by the end of 2025 from a valuation of around US$ 2,033 Mn in 2017.

Our Clients

Our Clients